According to Global Data, oncology is the top therapy area for clinical trials initiated in 2018; most industry sponsored trials are for solid tumors; and, among all clinical trials, immune oncology drugs are the most common. North America, Europe and Asia-Pacific account for more than 90% of all trial locations, with most of the North American trial sites based in the U.S. (CLINICAL LEADER)